OverviewSuggest Edit

PharmaCyte Biotech is a clinical-stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes. It uses its proprietary cellulose-based live-cell encapsulation technology known as Cell-in-a-Box. The company also offers cannabis-based drugs for medical use to treat conditions such as nausea, vomiting, and pain.
TypePublic
Founded1996
HQLaguna Hills, CA, US
Websitepharmacyte.com

Locations

PharmaCyte Biotech is headquartered in
Laguna Hills, United States

Location Map

Latest Updates

Employees (est.) (Apr 2019)4
Revenue (FY, 2020)$0
Share Price (Jul 2021)$14.9(-6%)
Cybersecurity ratingAMore

Key People/Management at PharmaCyte Biotech

Kenneth L. Waggoner

Kenneth L. Waggoner

Chief Executive Officer, President, General Counsel and Chairman of the Board
Thomas C. K. Yuen

Thomas C. K. Yuen

Director
Matthias Löhr

Matthias Löhr

Medical and Scientific Advisory Board Chairman
José Iglesias

José Iglesias

Consulting Chief Medical Officer
Gerald W. Crabtree

Gerald W. Crabtree

Chief Scientific Officer and Director
Michael M. Abecassis

Michael M. Abecassis

Director
Show more

PharmaCyte Biotech Office Locations

PharmaCyte Biotech has an office in Laguna Hills
Laguna Hills, CA, US (HQ)
23046 Avenida De La Carlota #600
Show all (1)

PharmaCyte Biotech Financials and Metrics

PharmaCyte Biotech Revenue

USD

Net income (Q3, 2021)

(757.1k)

EBIT (Q3, 2021)

(756.8k)

Market capitalization (21-Jul-2021)

22.5m

Closing stock price (21-Jul-2021)

14.9

Cash (31-Jan-2021)

3.1m

EV

19.5m
PharmaCyte Biotech's current market capitalization is $22.5 m.
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

66.6k12.2k

Cost of goods sold

19.4k9.6k

Gross profit

47.2k2.5k

Gross profit Margin, %

71%21%
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Revenue

19.8k19.8k20.3k

Cost of goods sold

15.7k6.0k2.2k

Gross profit

4.1k13.8k18.1k

Gross profit Margin, %

21%70%89%
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

15.7k199.3k3.6m2.7m1.9m3.5m1.1m515.3k894.9k

Accounts Receivable

2.6k

Prepaid Expenses

159.4k127.9k570.1k1.5m110.0k74.3k224.1k138.2k142.8k

Inventories

6.8k
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Cash

83.1k14.5k39.1k33.3k206.0k396.6k864.9k2.9m1.2m958.8k2.9m2.3m2.9m2.3m1.6m2.5m2.7m1.5m1.8m907.4k699.5k327.8k45.1k142.2k2.2m3.7m3.1m

Accounts Receivable

8.6k9.0k19.6k

Prepaid Expenses

32.9k98.3k76.1k675.8k172.1k124.6k38.2k103.0k410.6k8.4k54.4k51.1k21.7k104.3k88.4k120.8k30.2k8.5k149.3k164.3k67.0k136.5k95.0k41.7k

Inventories

7.6k4.5k2.3k
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(1.9m)(1.6m)(27.3m)(9.9m)(6.1m)(4.4m)(6.8m)(4.1m)(3.8m)

Depreciation and Amortization

24.7k

Inventories

(11.9k)6.8k

Accounts Payable

173.8k97.7k(59.2k)308.7k(160.7k)29.6k(13.0k)(230.7k)64.0k
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Net Income

(686.0k)(1.1m)(1.4m)(1.3m)(4.7m)(10.3m)(10.8m)(1.6m)(5.6m)(7.1m)(546.2k)(3.2m)(4.9m)(1.0m)(2.0m)(3.3m)(3.5m)(5.5m)(1.2m)(2.3m)(2.9m)(1.1m)(2.2m)(3.1m)(883.9k)(1.8m)(2.6m)

Depreciation and Amortization

8.5k16.4k23.9k

Inventories

(11.1k)(14.2k)(16.4k)6.8k

Accounts Payable

(13.2k)(2.8k)(32.0k)98.0k965.0(8.9k)(58.7k)16.3k84.1k187.7k(83.6k)(69.5k)200.6k(24.4k)(35.1k)99.0k(54.8k)(60.0k)222.4k(4.0k)(218.9k)(54.3k)42.7k218.6k199.0k(105.7k)(106.7k)
USDQ1, 2012

Financial Leverage

-0.7 x
Show all financial metrics

PharmaCyte Biotech Cybersecurity Score

Cybersecurity ratingPremium dataset

A

99/100

SecurityScorecard logo

PharmaCyte Biotech Online and Social Media Presence

Embed Graph

PharmaCyte Biotech Frequently Asked Questions

  • When was PharmaCyte Biotech founded?

    PharmaCyte Biotech was founded in 1996.

  • Who are PharmaCyte Biotech key executives?

    PharmaCyte Biotech's key executives are Kenneth L. Waggoner, Thomas C. K. Yuen and Matthias Löhr.

  • How many employees does PharmaCyte Biotech have?

    PharmaCyte Biotech has 4 employees.

  • Who are PharmaCyte Biotech competitors?

    Competitors of PharmaCyte Biotech include Olema Oncology, Diverse Biotech and TiumBio.

  • Where is PharmaCyte Biotech headquarters?

    PharmaCyte Biotech headquarters is located at 23046 Avenida De La Carlota #600, Laguna Hills.

  • Where are PharmaCyte Biotech offices?

    PharmaCyte Biotech has an office in Laguna Hills.

  • How many offices does PharmaCyte Biotech have?

    PharmaCyte Biotech has 1 office.